Daito Pharmaceutical Co Ltd (4577) Stock Price & News

4577:TYO

Daito Pharmaceutical Co Ltd

¥1,317.00

-0.30%

(-4.00) 1D

Nov 13, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4577...

Open

¥1,313

High

¥1,321

Low

¥1,308

Mkt. cap

38.00B

Avg. vol.

101.30K

Volume

50.80K

Dividend

3.04%

Quarterly dividend

¥10

Ex-dividend date

Nov 27, 2026

P/E ratio

12.06

52-wk high

¥1,521

52-wk low

¥1,120

EPS

¥109

Shares outstanding

12.51M

No. of employees

Open

¥1,313

High

¥1,321

Low

¥1,308

Mkt. cap

38.00B

Avg. vol.

101.30K

Volume

50.80K

Dividend

3.04%

Quarterly dividend

¥10

Ex-dividend date

Nov 27, 2026

P/E ratio

12.06

52-wk high

¥1,521

52-wk low

¥1,120

EPS

¥109

Shares outstanding

12.51M

No. of employees

Related stocks

2313

Compeq Manufacturing Co Ltd

NT$205.50

+4.85%

4526

Tongtai Machine & Tool Co Ltd

NT$57.40

+0.70%

3135

GoldKey Technology Corp

News stories

From web sources and news partners

The Motley Fool

1 hour ago

Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years

The Motley Fool

23 minutes ago

The S&P 500 Has Gone 18 Months Without a 10% Drop. Here's How the Next Year Has Gone After Streaks This Long.

Bloomberg.com

3 hours ago

SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger

Traders Union

1 hour ago

Tom McClellan: NYSE Composite Index better comparison for A-D Line than S&P 500

About Daito Pharmaceutical Co Ltd

CEO-

Employees1.08K

FoundedJun 30, 1942

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitedaitonet.co.jp

All values in JPY	Nov 2025	Feb 2026	May 2026	Aug 2026
Revenue	12.13B	11.59B	13.92B	11.89B
Cost of goods sold	9.92B	9.24B	11.14B	9.70B
Cost of revenue	9.92B	9.24B	11.14B	9.70B
Research and development expenses	-	-	2.22B	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.58B	1.23B	-327.00M	1.48B
Operating expense	1.58B	1.23B	1.90B	1.48B
Total operating expenses	11.50B	10.46B	13.03B	11.18B
Operating income	627.00M	1.13B	884.00M	713.00M
Other non operating income	102.00M	-1.00M	30.00M	9.00M
EBT including unusual items	782.00M	1.44B	796.00M	962.00M
EBT excluding unusual items	789.00M	1.21B	917.00M	807.00M
Income tax expense	237.00M	387.00M	-71.00M	245.00M
Effective tax rate	30.31%	26.97%	-8.92%	25.47%
Other operating expenses	-	-	-	-
Net income	537.00M	1.03B	894.00M	700.00M
Net profit margin	4.43%	8.92%	6.42%	5.89%
Earnings per share	-	-	-	-
Interest and investment income	7.00M	29.00M	-	38.00M
Interest expense	-33.00M	-33.00M	-34.00M	-30.00M
Net interest expenses	-26.00M	-4.00M	-34.00M	8.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	1.69B	2.21B	1.98B	1.81B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything